Search

Find exactly what you’re looking for.
Search

Showing 41-60 of 60 results

​The use of artificial intelligence (AI) to generate creative works raises interesting legal challenges to the protection of intellectual property. The plain language of the Copyright Act presents obstacles to artists who may use generative AI as part of their creative process. The U.S. Copyright...

Adam Fayne will be moderating a panel at the Cannabis & Psychedelics Investment Summit in Miami, Florida on February 27, 2023. The panel topic will be Investment 101 for Family Offices: An Introduction to investing in cannabis and psychedelics.

The use of artificial intelligence (AI) to create works of art creates interesting legal challenges to the protection of intellectual property. A copyright infringement class action lawsuit has been filed against providers of AI software that is used to generate visual works of art based on...

Zachary Kobrin spoke on a panel titled, “Opportunities and Challenges in the 2023 Cannabis Market” presented by Centri Business Consulting. This webinar featured a panel of experts discussing trending financial topics in the cannabis industry including: Recent updates in Capital Markets & SAFE...

​As the cannabis industry continues to grow and expand at a rapid pace, successful operators could become the targets of labeling class actions that have plagued the traditional food and beverage industry for decades, especially in plaintiff-friendly jurisdictions like California. Suits related to...
​As interest in psychedelics rises, amidst the decriminalization of psychedelic substances in various jurisdictions and the regulation of the provision of psilocybin services in Oregon, institutions of higher education may find themselves wondering how to navigate the myriad questions that come...

The use of artificial intelligence (AI) to create works of art and inventions raises interesting legal challenges to the protection of intellectual property (IP). The plain language of the Copyright Act and Patent Act present obstacles to inventors and artists who may use or be AI systems. Recent...

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

In this exciting presentation, Jonathan Havens, a former FDA regulator and Capitol Hill staffer, will discuss the current hemp and cannabinoid and regulatory landscapes, and how they might change.

Zachary Kobrin spoke on a panel titled, “Mock Negotiation: Buying/Selling A License” at The Marijuana Business Conference (MJBizCon) Cannabis Law Sessions presented by The International Cannabis Bar Association (INCBA). This panel featured a mock negotiation of the purchase/sale of a cannabis...

Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the 2022 Rowan University Cannabis Forum: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session will cover the implications of cannabis legislation on businesses and...

Ruth Rauls, a Partner in the firm's Cannabis Practice, will participate as a speaker during the Rowan University Cannabis Forum 2022: Assessing the Legalization of Cannabis in New Jersey on its Two-year Anniversary. Ruth's session is entitled "Implications of Cannabis Legislation on Businesses...

Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will speak during the 2022 Tobacco/OTP + CBD Forum in Orlando, FL.

MAKING SENSE OF PRES. BIDEN’S CANNABIS REFORM STATEMENT – FDA’S ROLE IN SCHEDULING EVALUATION Jonathan Havens, Co-Chair of the firm's Cannabis Practice, will discuss President Biden’s recent cannabis reform announcement, its implications for various stakeholders, and FDA’s role in evaluating how...

INTO THE RABBIT HOLE OF PSYCHEDELICS: EXPLORING MDMA, PSILOCYBIN, LSD, AYAHUASCA, DMT, IBOGAINE, KETAMINE, AND OTHER PSYCHEDELICS. Jonathan Havens, Co-Chair of the Firm's Cannabis Practice, will be speaking at the Psychedelic Medicine Conference/CBD Expo. Jonathan's panel will dive down the rabbit...

Jonathan Havens, Co-Chair of Saul Ewing's Cannabis Law Practice, will speak at The Cannabis and Psychedelics Investment Summit in London on September 20, 2022. Jonathan will be joining a panel entitled "A Legal Overview: The Future of Cannabis and Psychedelic Policy."

Background On August 25, 2022, after weeks of promotion by the New York Office of Cannabis Management (OCM), the application window has finally opened for adult-use cannabis dispensary licenses in the Empire State. These retail privileges, known as Conditional Adult-use Retail Dispensary (CAURD)...

EXPLORING THE REGULATION, LITIGATION AND ENFORCEMENT OF MARIJUANA Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, will speak at ACI’s Controlled Substances – Regulation, Litigation, and Enforcement Summit in Washington, DC on July 12th as a panelist during the session on “Exploring...

For More Information
Contact us